Whats New for Medicare in 2025
What’s new for 2025 The year 2025 marks a significant milestone for Medicare, introducing the most substantial changes since the 2006 Part D rollout. These adjustments, driven by the Inflation Reduction Act, aim to reduce financial strain on beneficiaries but may lead to shifts in insurance offerings. Key Changes $2,000 Annual Cap on Part D […]
New AARP Survey Finds Life is Good, Especially for Older Americans
Survey Finds Older Adults Have an Optimistic Outlook on Life; Expect Their Lives to Improve as They Get Older WASHINGTON—According to a new AARP survey exploring the second half of life, most older adults have an optimistic outlook on life and expect their lives to improve as they get older. Nearly 9 in 10 are […]
AARP Statement Following Announcement of First Medicare Negotiated Drug Prices
Medicare will now negotiate drug prices every year, thanks to the 2022 prescription drug law that AARP championed, benefitting millions of older Americans for years to come WASHINGTON—Today, AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services (CMS) […]
AARP Responds to 2024 Medicare and Social Security Trustees Reports
WASHINGTON—AARP CEO Jo Ann Jenkins issued the following statement in response to the Medicare and Social Security Trustees Reports released today: “While there was good news today in the Trustees Reports, older Americans need certainty that Medicare and Social Security will be protected. For long term sustainability, Congress owes it to the American people to […]
AARP Responds to 2024 State of the Union Address
WASHINGTON—Today, AARP CEO Jo Ann Jenkins issued the following statement in response to President Biden’s State of the Union address: “AARP was encouraged that the State of the Union addressed many of the most important issues to older Americans today, including protecting Social Security, lowering the cost of prescription drugs, and addressing our nation’s caregiving […]
AARP Statement on House Committee Approval on Fiscal Commission Legislation
WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement today following the House Budget Committee vote approving fiscal commission proposals that include Social Security and Medicare: “Today’s vote by the House Budget Committee sets up a process where 7 Members of Congress can ram through drastic cuts to […]
AARP Statement on New CMS Proposal to Require Minimum Nursing Home Staffing Levels
AARP Statement on New CMS Proposal to Require Minimum Nursing Home Staffing Levels WASHINGTON— AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services proposal to require federal minimum staffing levels in nursing homes. “COVID-19 revealed what AARP and […]
AARP Responds to First 10 Medicare Part D Drugs Selected for Historic Negotiation
AARP Responds to First 10 Medicare Part D Drugs Selected for Historic Negotiation WASHINGTON— AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services’ list of the first 10 drugs to be negotiated for lower prices by Medicare: “AARP […]
New Report: Top Medicare Part D Drugs Have More Than Tripled in Price Since Entering Market
New Report: Top Medicare Part D Drugs Have More Than Tripled in Price Since Entering Market WASHINGTON — List prices for the 25 brand-name drugs with the highest total Medicare Part D spending in 2021 have increased by an average of 226%—or more than tripled—since they first entered the market, a new report from AARP’s […]
AARP Applauds CMS’ Final Guidance for Medicare Negotiation Implementation to Lower Drug Prices
AARP Applauds CMS’ Final Guidance for Medicare Negotiation Implementation to Lower Drug Prices WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services’ final implementation guidance of the Medicare Drug Price Negotiation Program: “AARP commends CMS for issuing final […]
